Used in biomedical research to measure levels of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) or total TAFI in plasma. Helps assess fibrinolytic system activity, which plays a key role in blood clot stability and breakdown. Widely applied in studies of thrombosis, bleeding disorders, and cardiovascular diseases. Enables researchers to investigate the role of TAFI in conditions like deep vein thrombosis, stroke, and sepsis. Also used in drug development to evaluate therapies targeting fibrinolysis regulation. Provides a reliable, sensitive method for quantifying TAFI in clinical and experimental samples.